We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+9.61%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$21.6B
AUM Growth
+$2.85B
Cap. Flow
+$1.11B
Cap. Flow %
5.1%
Top 10 Hldgs %
30.93%
Holding
1,357
New
41
Increased
770
Reduced
236
Closed
79

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$203M
2
NOW icon
ServiceNow
NOW
+$181M
3
PSA icon
Public Storage
PSA
+$132M
4
ELS icon
Equity Lifestyle Properties
ELS
+$129M
5
OHI icon
Omega Healthcare
OHI
+$114M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$188M
2
SNOW icon
Snowflake
SNOW
+$152M
3
IRM icon
Iron Mountain
IRM
+$149M
4
PLD icon
Prologis
PLD
+$131M
5
AMT icon
American Tower
AMT
+$100M

Sector Composition

Rank Sector Weight
1 Real Estate 41.83%
2 Technology 20.16%
3 Communication Services 6.63%
4 Financials 5.64%
5 Consumer Discretionary 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XNCR icon
1176
Xencor
XNCR
$1.48B
$4K ﹤0.01%
222
– –
ZYME icon
1177
Zymeworks
ZYME
$1.66B
$4K ﹤0.01%
286
– –
ABCL icon
1178
AbCellera Biologics
ABCL
$1.62B
$3K ﹤0.01%
1,151
– –
ADPT icon
1179
Adaptive Biotechnologies
ADPT
$3.6B
$3K ﹤0.01%
530
– –
BNS icon
1180
Scotiabank
BNS
$108B
$3K ﹤0.01%
50
– –
CNTA
1181
DELISTED
Centessa Pharmaceuticals
CNTA
$3K ﹤0.01%
211
– –
ERAS icon
1182
Erasca
ERAS
$6.3B
$3K ﹤0.01%
1,074
+720
+203% +$2.03K
ETNB
1183
DELISTED
89bio
ETNB
$3K ﹤0.01%
344
– –
KNSA icon
1184
Kiniksa Pharmaceuticals
KNSA
$6.11B
$3K ﹤0.01%
139
– –
OLMA icon
1185
Olema Pharmaceuticals
OLMA
$1.01B
$3K ﹤0.01%
224
– –
ORIC icon
1186
Oric Pharmaceuticals
ORIC
$1.23B
$3K ﹤0.01%
249
– –
PCRX icon
1187
Pacira BioSciences
PCRX
$1.05B
$3K ﹤0.01%
169
– –
PRTA icon
1188
Prothena Corp
PRTA
$448M
$3K ﹤0.01%
195
– –
RLAY icon
1189
Relay Therapeutics
RLAY
$3.99B
$3K ﹤0.01%
486
– –
SANA icon
1190
Sana Biotechnology
SANA
$916M
$3K ﹤0.01%
767
– –
TNGX icon
1191
Tango Therapeutics
TNGX
$4.34B
$3K ﹤0.01%
355
– –
VWO icon
1192
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$3K ﹤0.01%
55
+41
+293% +$1.82K
WVE icon
1193
Wave Life Sciences
WVE
$1.13B
$3K ﹤0.01%
349
– –
XLP icon
1194
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$3K ﹤0.01%
32
– –
PETQ
1195
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$3K ﹤0.01%
99
– –
ABUS icon
1196
Arbutus Biopharma
ABUS
$871M
$2K ﹤0.01%
395
– –
ARCT icon
1197
Arcturus Therapeutics
ARCT
$163M
$2K ﹤0.01%
90
– –
AVXL icon
1198
Anavex Life Sciences
AVXL
$238M
$2K ﹤0.01%
314
– –
BCYC
1199
Bicycle Therapeutics
BCYC
$275M
$2K ﹤0.01%
103
– –
CSTL icon
1200
Castle Biosciences
CSTL
$725M
$2K ﹤0.01%
86
– –
46 47
48
49 50

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2024 Portfolio in Review

As of Q3 2024, Daiwa Securities Group held 1,357 positions worth $21.6B, up 15% from $18.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa Securities Group deployed $1.11B of net new capital in Q3 2024, opening 41 new positions and adding to 770 existing holdings. Its largest new stake was Lineage Inc: 465,245 shares worth $36.5M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Tesla, an estimated $188M trimmed.

  • Daiwa Securities Group's largest Q3 2024 buy was Lineage Inc: 465,245 shares worth $36.5M.
  • Daiwa Securities Group added most to CrowdStrike in Q3 2024, an estimated $203M increase.
  • Daiwa Securities Group's biggest Q3 2024 reduction was Tesla, cutting an estimated $188M.
  • Daiwa Securities Group fully exited Lam Research in Q3 2024, selling an estimated $26.6M.
  • Daiwa Securities Group's ten largest holdings make up 31% of its $21.6B portfolio in Q3 2024.
  • Daiwa Securities Group opened 41 new positions and closed 79 in Q3 2024.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $21.6B.

Based on Daiwa Securities Group's 13F filing for Q3 2024, filed 12 Nov 2024.